CSBR vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

CSBR

38.1
AI Score
VS
CBIO Wins

CBIO

45.7
AI Score

Investment Advisor Scores

CSBR

38score
Recommendation
SELL

CBIO

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CSBR CBIO Winner
Revenue 45.59M 1.04M CSBR
Net Income -508,000 -48.12M CSBR
Net Margin -1.1% -4631.4% CSBR
Operating Income -618,000 -51.09M CSBR
ROE -11.9% -29.5% CSBR
ROA -1.8% -26.3% CSBR
Total Assets 28.45M 182.76M CBIO
Cash 7.13M 171.59M CBIO
Current Ratio 0.98 9.66 CBIO
Free Cash Flow -2.80M -28.56M CSBR

Relative Price Performance (Last 90 Days)

CSBR 1M: +0.0% · 3M: -3.8% CBIO 1M: -13.0% · 3M: -17.7%

Current Technical Phase

CSBR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.7 · Price: $5.76

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.2%), weak momentum, RSI 41

RSI (14): 41.2 · Price: $14.87

Fundamentals Snapshot

Metric CSBR CBIO
Market Cap
Forward P/E 57.6 -5.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.5% 1.0%
Operating Margin 0.0% -14.3%
EPS -0.08 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.